FDA-Inspected Site

Unimed Pharmaceuticals, Inc.

2 FDA inspections are on record for Unimed Pharmaceuticals, Inc. in Cheongju, Korea (the Republic of).

Clean· No action indicated

Cheongju, Korea (the Republic of) · Last updated July 10, 2026

Overview

  • 2 FDA inspections are on record.
  • 1 inspection produced a Form 483.
  • The most recent recorded inspection date is 2023-02-14.

At a glance

Inspections

2

Form 483s

1

EIRs

1

Last outcome

Clean

Inspection history

FDA inspections on record, most recent first.

InspectionCategoryOutcomeForm 483
6 Feb 2023 – 14 Feb 2023Human DrugsClean
8 May 2018 – 16 May 2018Human Drugs483View 483 →

Observations on record

Form 483 observations cited at this site, most recent first.

16 May 2018
21 CFR 211.68(b)

Computer control of master formula records

Cited by Sangeeta M Khurana

Investigators

FDA investigators tied to this site in the record.

Recurring citations

CFR citation patterns observed across this site's inspections.

CitationWhat it coversCited
21 CFR 211.68(b)Cited across public-safe Form 483 observations1x

Full site report

Get the verbatim findings behind Unimed Pharmaceuticals, Inc.'s 1 Form 483

Source PDFs, verbatim observations, and recurring CFR citations, so your team knows what this site gets cited for.

  • The site's full inspection history, with every Form 483 and its outcome
  • Warning letters and recalls tied to the company behind it
  • Whether recurring CFR citations get closed out or repeat